Ependymoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 21: | Line 21: | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 20:14, 20 August 2015
Ependymoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ependymoma medical therapy On the Web |
American Roentgen Ray Society Images of Ependymoma medical therapy |
Risk calculators and risk factors for Ependymoma medical therapy |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Medical Therapy
- The malignant (anaplastic) varieties of this tumor, malignant ependymoma and the ependymoblastoma, are treated similarly to medulloblastoma but the prognosis is much less favorable. Malignant ependymomas may be treated with a combination of radiation therapy and chemotherapy.
Radiation Therapy
- For this reason, well-differentiated ependymomas are usually treated with radiation therapy only. Ependymoblastomas, which occur in infants and children younger than 5 years of age, may spread through the cerebrospinal fluid and usually require radiation therapy. The subependymoma, a variant of the ependymoma, is apt to arise in the fourth ventricle but may occur in the septum pellucidum and the cervical spinal cord.